Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HIND is expected to report earnings to rise 26.67% to -18 cents per share on August 13
Q2'26
Est.
$-0.19
Q1'26
Missed
by $0.05
Q4'25
Missed
by $0.08
The last earnings report on May 28 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 29.64K shares outstanding, the current market capitalization sits at 15.30M.